Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PDL Biopharma

PDL Biopharma?uq=x1rNslWr
1986 FOUNDED
PUBLIC STATUS
81-90 EMPLOYEES
PDLI STOCK SYMBOL
6 INVESTMENTS
$2.98 SHARE PRICE (As of Friday Closing)
Description

Developer of oncology drugs. The company is involved in the humanization of monoclonal antibodies and the development of a new process of targeted treatments for cancer and other immunologic diseases.

Website
Formerly Known As
Protein Design Labs
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 932 Southwood Boulevard
  • Incline Village, NV 89451
  • United States

+1 (775) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PDL Biopharma’s full profile, request a free trial.

PDL Biopharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.28 - $3.12 $439M $3.01 -$0.43 1.59M 146M

PDL Biopharma Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 107,695 147,032 400,490 683,317
Revenue 203,283 302,316 213,897 554,246
EBITDA (43,778) 212,400 108,691 520,667
Net Income (62,802) 110,748 63,606 332,795
Total Assets 984,427 1,243,123 1,215,387 1,012,205
Total Debt 122,780 243,481 232,443 253,828
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PDL Biopharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PDL Biopharma‘s full profile, request access.

Request full access to PitchBook

PDL Biopharma Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000 06-Jul-2016 000000000 00000 Pharmaceuticals 0000 0000000000 00
000000 14-Nov-2014 0000 000.00 Therapeutic Devices
0000000 22-Apr-2013 000000000 0000 Therapeutic Devices
000000 11-Oct-2012 00000 00000 00 0000 Therapeutic Devices
ESP Pharma 24-Mar-2005 Merger/Acquisition 00000 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

PDL Biopharma Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 14-Nov-2014 0000 000.00 Completed
  • 2 buyers
0000000 22-Apr-2013 000000000 0000 Completed
  • 000 000000000
AxoGen 11-Oct-2012 Later Stage VC 0000 Completed
  • 2 buyers
To view this company’s complete exits history, request access »

PDL Biopharma Subsidiaries (1)

Company Name Industry Location Founded
00000 000000 Acquirer Dublin, Ireland
To view this company’s complete subsidiary history, request access »

PDL Biopharma Executive Team (12)

Name Title Board
Seat
Contact
Info
John McLaughlin JD President, Director & Chief Executive Officer
Dominique Monnet President
Peter Garcia Vice President & Chief Financial Officer
Steffen Pietzke Controller & Chief Accounting Officer
Roz Sweeney Director, Business Development

4 Former Executives

You’re viewing 5 of 12 executives. Get the full list »